Senti Biosciences, Inc. (SNTI) Stock price, Description, News & Info

#Thinksabio latest news

Senti Bio Participates in Virtual Investor “What This Means” Segment Discussing The Phase 2 Dose and Schedule Selection for SENTI-202 in its Clinical Trial for Acute Myeloid Leukemia